Article

Tweaks made to CDC COVID-19 symptom list

Author(s):

The CDC has updated the COVID-19 symptom list to include congestion or runny nose, nausea or vomiting, and diarrhea.

coronavirus updates


This week, the CDC updated the COVID-19 symptom list to include congestion or runny nose, nausea or vomiting, and diarrhea. By themselves, these symptoms do not establish a definitive diagnosis of infection, but warrant attention in the current environment.

According to the most recent update as reported by BGR Media, the CDC recently changed the list of factors that can contribute to development of a severe case of the virus.

Age alone is now not a risk factor for development of a severe case. Older age was considered to be a red flag for developing some of the worst cases, but the thinking has changed. Another recent change was the addition of pregnancy to the list of higher risk situations, and finally the body mass index threshold was lowered from 40 to 30 as a risk factor.

Any of the following disease in persons of any age can result in a severe case of COVID-19: chronic kidney disease; chronic obstructive pulmonary disease); an immunocompromised state from solid organ transplant; obesity; heart failure, coronary artery disease, or cardiomyopathies; sickle cell disease; and type 2 diabetes mellitus.

These changes reflect new observations about the virus that likely will continue to change with increasing study.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.